Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Sucralfate
Treatment for Gastritis and duodenitis
Typical Dosage: 1g four times daily (before meals and at bedtime)
Effectiveness
68%
Safety Score
83%
Clinical Trials
400
Participants
40K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
83
DangerousModerateSafe
Treatment Details
Dosage Range
1g four times daily (before meals and at bedtime)
Time to Effect
Days for symptom relief, 4-8 weeks for healing
Treatment Duration
4-8 weeks
Evidence Quality
MODERATENumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$600
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$660
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$25,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$943
Cost per Remission
$1,100
Comparison vs Omeprazole (PPI)
Cost Difference
+$390/year
More expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$495
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$125/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$600/year
Potential OTC Price
$200/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWSucralfate Outcomes
for Gastritis and duodenitis
Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+70%
Remission Rate
+60%
Common Side Effects
Constipation
+6%
Dry mouth
+3%
Nausea
+1%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov